Hyper-oncotic albumin administration reduces mortality in acute Respiratory Distress Syndrome compared to crystalloid: a systematic review and meta-analysis

Key Points

• To assess the effect of hyper-oncotic albumin on mortality and oxygenation in ARDS patients compared to crystalloids.
• Conducted a systematic review and meta-analysis of existing studies.
• Included randomized controlled trials comparing hyper-oncotic albumin with crystalloid solutions.
• Evaluated mortality rates and early oxygenation findings across studies.
• Hyper-oncotic albumin administration is associated with reduced mortality in ARDS patients.
• Improved early oxygenation was observed with hyper-oncotic albumin compared to crystalloids.
• Findings highlight a potential clinical benefit, although larger trials are needed for confirmation.